» Articles » PMID: 33006048

The Relationship Between Cognition, Depression, Fatigue, and Disability in Patients with Multiple Sclerosis

Overview
Journal Ir J Med Sci
Specialty General Medicine
Date 2020 Oct 2
PMID 33006048
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Multiple sclerosis (MS) is a chronic, progressive, and neurodegenerative central nervous system disorder. MS usually causes disability, cognitive deficiency, fatigue, and depression symptoms.

Objectives: To assess cognitive functions of people with MS (pwMS) and investigate the impact of depression, fatigue, and disability on cognitive functions.

Methods: We administered the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery to assess 200 pwMS. The Expanded Disability Status Scale (EDSS) was used to evaluate disability levels. Fatigue Severity Scale (FSS) and the Beck Depression Inventory (BDI) were used, respectively, for fatigue and depression levels.

Results: EDSS and FSS scores were significantly higher in those with a disease duration of 5 years or more. Those with the EDSS ≥ 4 were found to have lower BICAMS performances and higher FSS scores. There was a significant difference in Symbol Digit Modalities Test (SDMT) performances between the groups with and without fatigue (FSS ≥ 4 and FSS < 4, respectively). When depression and fatigue symptoms concur or in the existence of just one of them or none of them, significant differences in terms of SDMT performances have been shown.

Conclusion: The level of disability and fatigue adversely affects the cognitive functions of pwMS; depression has no significant effect. BICAMS that is specific for MS can be beneficial to assess the cognitive state of pwMS.

Citing Articles

Association between CD20 T lymphocytes and neuropsychological findings in multiple sclerosis.

Esposito A, Falco F, Scalia G, Gentile L, Spiezia A, Corsini G Eur J Neurol. 2024; 32(1):e16536.

PMID: 39475271 PMC: 11625923. DOI: 10.1111/ene.16536.


The relationship between cognitive function and functional capacity, and cognitive reserve and reaction time in patients with multiple sclerosis.

Candiri B, Ramazanoglu E, Talu B, Tecellioglu M Arq Neuropsiquiatr. 2024; 82(9):1-9.

PMID: 39187267 PMC: 11500285. DOI: 10.1055/s-0044-1788273.


Depression and anxiety in multiple sclerosis. Review of a fatal combination.

Jellinger K J Neural Transm (Vienna). 2024; 131(8):847-869.

PMID: 38869643 DOI: 10.1007/s00702-024-02792-0.


Cognitive impairment in multiple sclerosis: from phenomenology to neurobiological mechanisms.

Jellinger K J Neural Transm (Vienna). 2024; 131(8):871-899.

PMID: 38761183 DOI: 10.1007/s00702-024-02786-y.


Understanding the association between fatigue and neurocognitive functioning in patients with glioma: A cross-sectional multinational study.

Rottgering J, Taylor J, Brie M, Luks T, Hervey-Jumper S, Phan S Neurooncol Pract. 2024; 11(3):284-295.

PMID: 38737609 PMC: 11085845. DOI: 10.1093/nop/npae011.


References
1.
Kutzelnigg A, Lucchinetti C, Stadelmann C, Bruck W, Rauschka H, Bergmann M . Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain. 2005; 128(Pt 11):2705-12. DOI: 10.1093/brain/awh641. View

2.
Chiaravalloti N, DeLuca J . Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008; 7(12):1139-51. DOI: 10.1016/S1474-4422(08)70259-X. View

3.
Wallin M, Wilken J, Kane R . Cognitive dysfunction in multiple sclerosis: Assessment, imaging, and risk factors. J Rehabil Res Dev. 2006; 43(1):63-72. DOI: 10.1682/jrrd.2004.09.0120. View

4.
Benedict R, Cookfair D, Gavett R, Gunther M, Munschauer F, Garg N . Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc. 2006; 12(4):549-58. DOI: 10.1017/s1355617706060723. View

5.
Langdon D . Cognition in multiple sclerosis. Curr Opin Neurol. 2011; 24(3):244-9. DOI: 10.1097/WCO.0b013e328346a43b. View